Expansion of Effector Memory TCR Vbeta4+ CD8+ T Cells is Associated with Latent Infection-mediated Resistance to Transplantation Tolerance
Overview
Authors
Affiliations
Therapies that control largely T cell-dependent allograft rejection in humans also possess the undesirable effect of impairing T cell function, leaving transplant recipients susceptible to opportunistic viruses. Prime among these opportunists are the ubiquitous herpesviruses. To date, studies are lacking that address the effect of viruses that establish a true latent state on allograft tolerance or the effect of tolerance protocols on the immune control of latent viruses. By using a mixed chimerism-based tolerance-induction protocol, we found that mice undergoing latent infection with gammaHV68, a murine gamma-herpesvirus closely related to human gamma-herpesviruses such as EBV and Kaposi's sarcoma-associated herpesvirus, significantly resist tolerance to allografts. Limiting the degree of virus reactivation or innate immune response did not reconstitute chimerism in latently infected mice. However, gammaHV68-infected mice showed increased frequency of CD8+ T cell alloreactivity and, interestingly, expansion of virus-induced, alloreactive, "effector/effector memory" TCR Vbeta4+CD8+ T cells driven by the gammaHV68-M1 gene was associated with resistance to tolerance induction in studies using gammaHV68-M1 mutant virus. These results define the viral gene and immune cell types involved in latent infection-mediated resistance to allograft tolerance and underscore the influence of latent herpesviruses on allograft survival.
Koritzinsky E, Tsuda H, Fairchild R Transpl Int. 2021; 34(8):1360-1373.
PMID: 33963616 PMC: 8389524. DOI: 10.1111/tri.13900.
Espinosa J, Mou D, Adams B, DiBernardo L, MacDonald A, McRae M Front Immunol. 2018; 9:1371.
PMID: 29963060 PMC: 6013589. DOI: 10.3389/fimmu.2018.01371.
Burrack A, Landry L, Siebert J, Coulombe M, Gill R, Nakayama M J Immunol. 2018; 200(4):1504-1512.
PMID: 29311365 PMC: 5809255. DOI: 10.4049/jimmunol.1700856.
Kim S, Wang J, Dong Y, Mathews D, Albrecht J, Breeden C Transplant Direct. 2017; 3(6):e161.
PMID: 28620645 PMC: 5464780. DOI: 10.1097/TXD.0000000000000677.
CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.
Khiew S, Yang J, Young J, Chen J, Wang Q, Yin D JCI Insight. 2017; 2(9).
PMID: 28469082 PMC: 5414557. DOI: 10.1172/jci.insight.92033.